Edition:
United States

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

66.70EUR
14 Jun 2019
Change (% chg)

€0.44 (+0.66%)
Prev Close
€66.26
Open
€66.54
Day's High
€66.90
Day's Low
€65.90
Volume
702,588
Avg. Vol
876,116
52-wk High
€91.74
52-wk Low
€55.44

Select another date:

Fri, Jun 14 2019

Fresenius Medical agrees to settle Medicare billing fraud case

The U.S. Justice Department on Friday said it had reached a tentative settlement with dialysis services company Fresenius Medical Care resolving claims that it billed Medicare for medically unnecessary hepatitis B tests.

Shareholders reproach Germany's Fresenius Medical Care after foreign bribery case

* ISS recommends no confidence vote on U.S. bribery settlement

UPDATE 2-Fresenius makes solid start to year after turbulent 2018

* Confirms full-year guidance (Adds analysts, shares, details)

Fresenius Medical Care to pay $231 million to resolve criminal, civil foreign bribery charges

Germany-based dialysis clinic operator Fresenius Medical Care AG will pay about $231 million to resolve criminal and civil allegations that the company paid bribes to public health and government officials in several countries to win or retain business, the U.S. Justice Department said on Friday.

UPDATE 2-Fresenius Medical Care to pay $231 mln to resolve criminal, civil foreign bribery charges

March 29 Germany-based dialysis clinic operator Fresenius Medical Care AG will pay about $231 million to resolve criminal and civil allegations that the company paid bribes to public health and government officials in several countries to win or retain business, the U.S. Justice Department said on Friday.

FMC wraps up $2 bln acquisition of NxStage

BERLIN, Feb 22 Germany's Fresenius Medical Care (FMC) wrapped up its $2 billion acquisition of U.S. home dialysis maker NxStage Medical on Friday, according to a U.S. Securities and Exchange Commission filing.

Fresenius flags faster earnings growth from 2020 after investment

BERLIN Fresenius expects earnings to grow faster than sales from 2020 after investments to improve its German hospitals and scale up its home dialysis business eat up profit this year, the German healthcare group said on Wednesday.

FMC expects NxStage deal to close in next couple of days

BERLIN Germany's Fresenius Medical Care (FMC) said on Wednesday it has won the green light from U.S. regulators to acquire U.S. home dialysis equipment maker NxStage and expects the deal to close in the next few days.

UPDATE 2-Fresenius flags faster earnings growth from 2020 after investment

* Announces 1 bln euros share buyback at Fresenius Medical Care

FMC expects NxStage deal to close in next couple of days

BERLIN, Feb 20 Germany's Fresenius Medical Care (FMC) said on Wednesday it has won the green light from U.S. regulators to acquire U.S. home dialysis equipment maker NxStage and expects the deal to close in the next few days.

Select another date: